Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphoma.

@article{Rodgers2018TargetingTB,
  title={Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphoma.},
  author={Thomas D Rodgers and Patrick M Reagan},
  journal={Expert opinion on emerging drugs},
  year={2018},
  volume={23 2},
  pages={
          111-122
        }
}
INTRODUCTION The B-cell receptor (BCR) pathway is a crucial aspect of mature lymphocytes and is maintained in B-cell neoplasms. Many small module inhibitors targeting kinases within the BCR pathway are approved, with others in development, offering alternative treatment options to standard chemoimmunotherapy. Areas covered: This review covers both approved… CONTINUE READING